reductions

Amycretin (Novo Nordisk), a unimolecular agonist of glucagon-like peptide 1 (GLP-1) and amylin receptors, induced significant weight loss and hemoglobin A1c (HbA1c) reductions in patients with type 2 diabetes in …

New study findings published by investigators in JAMA Network Open highlight the benefits of consistent continuous glucose monitoring (CGM) use among adults with type 2 diabetes (T2D). The researchers found …

An estimated 38.1 million adults in the United States were diagnosed with diabetes in 2021, according to the Centers for Disease Control and Prevention. Of these, approximately 90% to 95% …